PROTAC, E3 Ligands & Proximity-Inducing Building Blocks
Lenalidomide
Lenalidomide
製品番号CH57002CAS番号191732-72-6
製品概要
クイックビュー
- 製品ファミリー
- PROTAC, E3 Ligands & Proximity-Inducing Building Blocks
- 化学名
- Lenalidomide
- 分子式
- C13H13N3O3
- 分子量
- 259.26
Lenalidomide is an IMiD compound identified by CAS 191732-72-6.
The verified record matches molecular formula C13H13N3O3, molecular weight 259.26, PubChem CID 216326, and InChIKey GOTYRUGSSMKFNF-UHFFFAOYSA-N.
Lenalidomide is reported in cereblon/IMiD and molecular-glue research literature; the identifiers below keep that research tied to the confirmed compound identity.
同定情報と仕様
| Catalog No. | CH57002 |
| CAS No. | 191732-72-6 |
| Chemical Name | Lenalidomide |
| Molecular Formula | C13H13N3O3 |
| Molecular Weight | 259.26 |
| PubChem CID | 216326 |
| IUPAC Name | 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione |
| InChIKey | GOTYRUGSSMKFNF-UHFFFAOYSA-N |
用途情報
- Cereblon/IMiD research: Lenalidomide is frequently referenced in literature discussing cereblon-associated IMiD chemistry.
- Molecular-glue research background: PubMed records connect Lenalidomide with molecular-glue research language in the published literature.
- Identity and catalog alignment: supports matching CAS 191732-72-6, formula C13H13N3O3, PubChem CID 216326, and InChIKey GOTYRUGSSMKFNF-UHFFFAOYSA-N.
補足材料情報
特性
- IMiD compound with an isoindolinone-linked glutarimide framework.
- Formula C13H13N3O3 and molecular weight 259.26 align between CHEMOS source data and PubChem.
- CAS and exact-name lookups both resolve to PubChem CID 216326.
関連技術資料
公開情報源
- Lenalidomide | PubChem CID 216326
- Catalytic in vivo protein knockdown by small-molecule PROTACs
Nature Chemical Biology, 2015
Product-family technical context
- Structural basis of PROTAC cooperative recognition for selective protein degradation
Nature Chemical Biology, 2017
Product-family technical context
- Structural Basis of PROTAC Cooperative Recognition for Selective Protein Degradation
Nature Chemical Biology, 2017
Product-family technical context
- Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation
ACS Medicinal Chemistry Letters, 2022
Product-family technical context
類似製品
材料選択の支援が必要ですか？
CHEMOSは製品適合性、目標構造、ルート上の課題、分析要件、プロジェクト別供給ニーズを確認します。